Malaysian Genomics Resource Centre Bhd (XKLS:0155) Total Debt per Share: RM0.01 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0155 Malaysian Genomics Resource Centre Bhd XKLS:0155
48 GF Score
Price RM0.31
GF Value RM0.31
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Malaysian Genomics Resource Centre Bhd Total Debt per Share?

Malaysian Genomics Resource Centre Bhd XKLS:0155 48 Total Debt per Share is RM0.01 as of Mar. 2026. GuruFocus rates XKLS:0155 with a GF Score™ of 48/100 and a GF Value™ of RM0.31 (Fairly Valued). The stock has 3 warning signs investors should review.

RM0.01 (As of Mar. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Malaysian Genomics Resource Centre Bhd's Total Debt Per Share for the quarter that ended in Mar. 2026 was RM0.01.

Malaysian Genomics Resource Centre Bhd Total Debt per Share Related Terms

Malaysian Genomics Resource Centre Bhd Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Malaysian Genomics Resource Centre Bhd's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Malaysian Genomics Resource Centre Bhd Total Debt per Share Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.01 0.01 0.01 0.01

Malaysian Genomics Resource Centre Bhd Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01
XKLS:0155
48GF Score
Malaysian Genomics Resource Centre Bhd XKLS:0155
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Malaysian Genomics Resource Centre Bhd Total Debt per Share Calculation

Malaysian Genomics Resource Centre Bhd's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.92+0.31)/137.21
=0.01

Malaysian Genomics Resource Centre Bhd's Total Debt Per Share for the quarter that ended in Mar. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.84+0.31)/150.93
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of RM0.01 mean?
Malaysian Genomics Resource Centre Bhd (XKLS:0155) has a Total Debt per Share of RM0.01 as of Mar. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors.
Is Malaysian Genomics Resource Centre Bhd's Total Debt per Share too high?
Malaysian Genomics Resource Centre Bhd's current Total Debt per Share is RM0.01. Overall, Malaysian Genomics Resource Centre Bhd has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Malaysian Genomics Resource Centre Bhd's Total Debt per Share compare to TMO and DHR?
Malaysian Genomics Resource Centre Bhd's Total Debt per Share of RM0.01 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Medical Diagnostics & Research company?
A good Total Debt per Share depends on the Medical Diagnostics & Research industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. Malaysian Genomics Resource Centre Bhd's current Total Debt per Share is RM0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Malaysian Genomics Resource Centre Bhd stock overvalued right now?
Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd (XKLS:0155) is currently considered Fairly Valued. The stock's GF Value™ is RM0.31, compared to a current price of RM0.31 — trading right at its estimated fair value. The current Total Debt per Share is RM0.01. Malaysian Genomics Resource Centre Bhd's overall GF Score™ is 48/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Malaysian Genomics Resource Centre Bhd (XKLS:0155), the current Total Debt per Share is RM0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Malaysian Genomics Resource Centre Bhd (XKLS:0155) Overvalued in 2026?

Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd stock appears to be undervalued. The current stock price of RM0.31 is trading 0% below its estimated GF Value™ of RM0.31. GuruFocus considers Malaysian Genomics Resource Centre Bhd to be Fairly Valued.

Key valuation signals for XKLS:0155:

  • Total Debt per Share: RM0.01
  • GF Value™: RM0.31 vs. price of RM0.31 (0% below fair value)
  • GF Score™: 48/100 with 3 warning signs

No single metric tells the full story. See the XKLS:0155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Malaysian Genomics Resource Centre Bhd Business Description

Address Jalan Teknologi 3/6, 8F, Taman Sains Selangor 1, Kota Damansara (PJU5), Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services and genetic screening services (GSS). The group offerings include precision genetic screening, project-based analysis, and high-quality cell therapy and cosmeceutical products. The reportable segments of the Group derive their revenue from the provision of personalised and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services within the healthcare segment.
48GF Score

Get the complete analysis for XKLS:0155

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.31
Price
RM0.31
GF Value